Flagship explainer
What drives ImmuCell Corporation’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$1M | FY2025 |
| |
| Income before tax | −$1M | FY2025 |
|
| Operating income | $1.6M | FY2025 |
|
| $27.6M | FY2025 |
| |
| Ending assets | $42.5M | FY2025 |
|
| Beginning assets | $45.1M | FY2024 |
|
| $27.1M | FY2025 |
| |
| $27.5M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001013762-25-004072
- SEC filingFiling detailsAccession 0001437749-26-010339